WorldCat Identities

Reiner, Željko

Overview
Works: 40 works in 48 publications in 4 languages and 76 library holdings
Genres: Conference papers and proceedings  History  Biography 
Roles: Author, Editor
Publication Timeline
.
Most widely held works by Željko Reiner
Compendium of Abridged ESC Guidelines 2011 by Jeroen J Bax( )

5 editions published in 2012 in English and held by 16 WorldCat member libraries worldwide

A compendium comprising all of the ""ESC Pocket Guidelines"" updated since the publication of the 2010 guidelines. This is a full reference work for Cardiologists
Proceedings of the First International Postgraduate Course in Endocrinology : hormones and cancer : October 15-25, 1980, Dubrovnik, Yugoslavia by International Postgraduate Course in Endocrinology( Book )

2 editions published in 1983 in English and held by 6 WorldCat member libraries worldwide

Prevencija ateroskleroze : utjecaj prehrane : zbornik radova sa Znanstvenog skupa održanog 14. travnja 2003. u Zagrebu( Book )

2 editions published in 2005 in Croatian and held by 3 WorldCat member libraries worldwide

50 godina Akademije medicinskih znanosti Hrvatske by Akademija medicinskih znanosti Hrvatske( Book )

1 edition published in 2011 in Croatian and held by 3 WorldCat member libraries worldwide

Prevencija ateroskleroze : arterijska hipertenzija kao čimbenik rizika : zbornik radova sa Znanstvenog skupa održanog 7. travnja 2004. u Zagrebu( Book )

2 editions published in 2006 in Croatian and held by 3 WorldCat member libraries worldwide

Lipoproteini in patofiziologija ateroskleroze by Željko Reiner( )

1 edition published in 1989 in Slovenian and held by 2 WorldCat member libraries worldwide

Pomen apoproteinov v presnovi lipoproteinov : apoproteini so na splošno dobri kazalci nevarnosti nastajanja ateroskelroze pri hiperlipoproteinemijah by Željko Reiner( )

1 edition published in 1990 in Slovenian and held by 2 WorldCat member libraries worldwide

Prevencija ateroskleroze : jesu li žene drugačije od muškaraca? : Zbornik radova sa Znanstvenog skupa održanog 4. travnja 2007. u Zagrebu( Book )

1 edition published in 2008 in Croatian and held by 2 WorldCat member libraries worldwide

Oksidacija lipoproteinov - ključni proces pri razvoju ateroskleroze by Željko Reiner( )

1 edition published in 1995 in Slovenian and held by 2 WorldCat member libraries worldwide

Farmakoterapijski priručnik by Igor Francetić( Book )

2 editions published between 2004 and 2007 in Croatian and held by 2 WorldCat member libraries worldwide

Pomen primarne in sekundarne preventive kardiovaskularnih bolezni by Željko Reiner( )

1 edition published in 1991 in Slovenian and held by 2 WorldCat member libraries worldwide

Vloga zdravnika splošne prakse v diagnosticiranju in zdravljenju hiperlipidemij by Željko Reiner( )

1 edition published in 1997 in Slovenian and held by 2 WorldCat member libraries worldwide

Prevencija ateroskleroze : novi čimbenici rizika : zbornik radova sa Znanstvenog skupa održanog u Zagrebu 10. travnja 2001. godine by Znanstveni skup Prevencija ateroskleroze: novi čimbenici rizika( Book )

1 edition published in 2002 in Croatian and held by 2 WorldCat member libraries worldwide

Vloga statinov v preprečevanju srčno-žilnih bolezni = The role of statins in the prevention of cardiovascular diseases by Željko Reiner( )

1 edition published in 2002 in Slovenian and held by 2 WorldCat member libraries worldwide

The HMG-CoA reductase inhibitors, often referred to as the statins, are inhibitors of cholesterol synthesis in hepatocytes. They are specific, competitive inhibitors of the enzyme HMG-CoA reductase, which catalyses the first step in cholesterol synthesis - the conversion of HMG-CoA to mevalonate. As a result, hepatic LDL-receptor activity increases, leading to increased uptake of LDL and decreased plasma total and LDL cholesterol. Several secondary prevention studies (4S, CARE, LIPID) in the last decade haveclearly demonstrated that secondary prevention of coronary heart disease (CHD) with statins should be essential treatment because it signi ficantly reduces cardiovascular morbidity and mortality and is cost-effective. There isincreasing evidence, particularly from primary prevention studies (WOSCOP, AFCAPS/TexCAPS), that statins should be used in primary prevention of CHD as well, especially for high risk patients. The greater is the total and LDL cholesterol reduction, the better is the risk lowering effect. However, the beneficial effects of statins should not only be attributed to their cholesterol-lowering effects. They also reduce the enhanced susceptibility to oxidation of LDL particles, restore endothelial dysfunction, prevent arterial smooth muscle cell migration and proliferation, reduce platelet aggregation, improve impaired fibrinolysis and stabilize the plaque. Apart from these antiatherogenic effects they seem to increase bone formation, thus possibly reducing the risk of osteoporotic fractures, and may inhibit tumour cell growth as well
Ali je ateroskleroza vnetna bolezen? by Željko Reiner( )

1 edition published in 2000 in Slovenian and held by 2 WorldCat member libraries worldwide

Lipoprotein (a) by Željko Reiner( )

1 edition published in 1994 in Slovenian and held by 2 WorldCat member libraries worldwide

Vpliv nekaterih živil in prehrambenih dodatkov na ravni serumskih lipoproteinov by Željko Reiner( )

1 edition published in 1996 in Slovenian and held by 2 WorldCat member libraries worldwide

Compendium of Abridged ESC Guidelines 2011 [recurso electrónico] $c by Jeroen J Bax( )

1 edition published in 2012 in English and held by 1 WorldCat member library worldwide

Section I: Prevention of Cardiovascular Disease -- Section II: Hypertension; 1 -- Section III: Diabetic Heart Disease.- Section IV: Coronary Heart Disease -- Section V: Myocardial Disease -- Section VI: Pericardial Disease -- Section VII: Congenital Heart Disease -- Section VIII: Pregnancy and Heart Disease -- Section IX: Valvular Heart Disease -- Section X: Infective Endocarditis -- Section XI: Pulmonary Hypertension -- Section XII: Arrhythmias -- Section XIII: Myocardial Infarction -- Section XIV: Pulmonary Embolism -- Section XV: Heart Failure -- Section XVI: Cardiac Consult
Usporedba učinaka fenofibrata primijenjenog u dozama od 3 x 100 mg i 1 x 250 mg na dan u bolesnika s hiperlipoproteinemijom tipa II a, II b i IV by Željko Reiner( )

1 edition published in 1990 in Serbian and held by 1 WorldCat member library worldwide

2016 ESC/EAS guidelines for the management of dyslipidaemias( )

1 edition published in 2016 in English and held by 1 WorldCat member library worldwide

 
moreShow More Titles
fewerShow Fewer Titles
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.83 (from 0.69 for Compendium ... to 0.97 for Prevencija ...)

Alternative Names
Rainer, Željko

Reiner, Ž.

Reiner, Zeljko 1953-

Željko Reiner Croatian politician and physician

Željko Reiner médecin et homme politique croate

Željko Reiner politicus uit Kroatië

Желько Райнер

Райнер, Желько

젤코 라이네르 크로아티아 의사, 정치인

澤利科·雷伊奈爾

Languages